Company · ALNY (Nasdaq)
Alnylam Pharmaceuticals, Inc.
Pharmaceutical Preparations
Key figures
- Revenue, 2025
- $3.71B
- Employees
- 115
- Industry
- Pharmaceutical Preparations (SIC 2834)
- Institutional holders
- 788 at 30 Jun 2026 (793 the quarter before)
- SEC number
- 1178670
- LEI
- 529900S3ZI14OWRJII50
Source: SEC EDGAR filings and company facts, SEC Form 13F; checked 27 Oct 2026
About
Alnylam Pharmaceuticals, Inc. is a biopharmaceutical company in pharmaceutical industry, headquartered in Cambridge, founded in 2002.
Source: Wikidata
Latest filings
Source: SEC EDGAR
With a free account
A free account opens 10 full pages a month and lets you follow this page: 12 quarters of figures, every filing and document, earnings call transcripts, holders and ownership changes, the Brain's cards and graph, exports to Excel.
Research from public records, not investment advice. Tamarly holds no investment positions. By reading these pages you accept the Terms of Use; figures can be late or wrong, so check the linked source before relying on one. Terms and policies.